GAMES
2
MIN
9.2
PTS
3.5
REB
1.5
AST
1.5
FG%
40.0
Season averages
| Season | Phase | Team | GP | GS | MIN | PTS | REB | AST | 3PM | S+B | FG% | 3P% | FT% | PIR |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Liga Endesa | ||||||||||||||
| 2026-27 | Regular season |  RMB | 2 | 0 | 9.2 | 3.5 | 1.5 | 1.5 | 0.0 | 0.5 | 40.0 | 0.0 | 50.0 | 2.5 |
| G League | ||||||||||||||
| 2025-26 | Regular season |  MNE | 26 | 23 | 33.5 | 15.7 | 4.3 | 6.9 | 2.5 | 1.9 | 43.6 | 39.5 | 73.8 | — |
| NBA | ||||||||||||||
| 2025-26 | Regular season |  BOS | 9 | 1 | 4.1 | 0.8 | 0.7 | 0.2 | 0.1 | 0.1 | 25.0 | 25.0 | 100.0 | — |
| G League | ||||||||||||||
| 2025-26 | Playoffs | MNE | 14 | 13 | 32.9 | 14.1 | 4.4 | 5.9 | 2.1 | 1.8 | 38.1 | 31.3 | 68.8 | — |
| NBA | ||||||||||||||
| 2025-26 | Playoffs | BOS | 2 | 0 | 2.5 | 1.5 | 0.0 | 0.0 | 0.5 | 0.0 | 50.0 | 50.0 | — | — |
Advanced — true shooting, usage, per-36 rates
| Season | Phase | GP | MIN | TS% | eFG% | USG% | TOV% | 3PAr | FTr | PTS/36 | REB/36 | AST/36 | S+B/36 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-26 G League | Regular season | 26 | 871 | 58.0 | 54.1 | 20.8 | 18.0 | 0.53 | 0.21 | 16.9 | 4.7 | 7.4 | 2.0 |
| 2025-26 NBA | Regular season | 9 | 37 | 39.4 | 31.3 | 13.9 | 25.3 | 0.50 | 0.25 | 6.8 | 5.8 | 1.9 | 1.0 |
| 2025-26 G League | Playoffs | 14 | 461 | 51.3 | 47.0 | 21.8 | 17.9 | 0.57 | 0.19 | 15.4 | 4.8 | 6.4 | 2.0 |
Box-score approximations: usage without play-by-play, shooting from season totals. Rates are per 36 minutes.
Season
2026-272025-26
Recent form
PointsReboundsAssistsThreesPts+Reb+Ast
Points+Reb+Ast over 21.5 in 0/10
Last 15 games — 2025-26
| Date | Opp | Result | MIN | PTS | REB | AST | 3PM | PRA | +/- |
|---|---|---|---|---|---|---|---|---|---|
| 2 May | vs PHI | L 100-109 | 0 | 0 | 0 | 0 | 0 | 0 | — |
| 30 Apr | @ PHI | L 93-106 | 0 | 0 | 0 | 0 | 0 | 0 | — |
| 28 Apr | vs PHI | L 97-113 | 0 | 0 | 0 | 0 | 0 | 0 | — |
| 26 Apr | @ PHI | W 128-96 | 3 | 3 | 0 | 0 | 1 | 3 | +6 |
| 24 Apr | @ PHI | W 108-100 | 0 | 0 | 0 | 0 | 0 | 0 | — |
| 21 Apr | vs PHI | L 97-111 | 2 | 0 | 0 | 0 | 0 | 0 | -1 |
| 19 Apr | vs PHI | W 123-91 | 0 | 0 | 0 | 0 | 0 | 0 | — |
| 12 Apr | vs ORL | W 113-108 | 18 | 3 | 3 | 0 | 1 | 6 | +8 |
| 10 Apr | vs NO | W 144-118 | 6 | 0 | 2 | 0 | 0 | 2 | -13 |
| 9 Apr | @ NY | L 106-112 | 0 | 0 | 0 | 0 | 0 | 0 | — |
| 7 Apr | vs CHA | W 113-102 | 0 | 0 | 0 | 0 | 0 | 0 | — |
| 5 Apr | vs TOR | W 115-101 | 0 | 0 | 0 | 0 | 0 | 0 | — |
| 3 Apr | @ MIL | W 133-101 | 0 | 0 | 0 | 0 | 0 | 0 | — |
| 1 Apr | @ MIA | W 147-129 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 31 Mar | @ GBO | L 90-112 | 31 | 5 | 3 | 8 | 1 | 16 | -2 |
Splits — 2025-26
| Split | GP | MIN | PTS | REB | AST |
|---|---|---|---|---|---|
| Home venue | 43 | 19.2 | 8.7 | 2.7 | 3.8 |
| Away venue | 33 | 16.6 | 7.3 | 2.0 | 3.0 |
| 0-1 days rest | 27 | 21.3 | 9.9 | 3.1 | 4.1 |
| 2-3 days rest | 35 | 12.7 | 6.7 | 1.4 | 2.3 |
| 4+ days rest | 13 | 24.0 | 7.5 | 3.2 | 5.0 |
| Season opener rest | 1 | 40.0 | 18.0 | 6.0 | 8.0 |
Hit rates by line — Points+Reb+Ast, 2025-26
PointsReboundsAssistsThreesPts+Reb+Ast
| Points+Reb+Ast line | Last 5 | Last 10 | Season |
|---|---|---|---|
| Over 2.5 | 3/560% | 7/1070% | 43/5184% |
| Over 3.5 – 5.5 | 2/540% | 6/1060% | 42/5182% |
| Over 6.5 – 12.5 | 1/520% | 4/1040% | 40/5178% |
| Over 13.5 | 1/520% | 4/1040% | 38/5175% |
| Over 14.5 – 15.5 | 1/520% | 4/1040% | 37/5173% |
| Over 16.5 – 17.5 | 0/50% | 3/1030% | 35/5169% |
| Over 18.5 | 0/50% | 3/1030% | 33/5165% |
| Over 19.5 | 0/50% | 2/1020% | 30/5159% |
| Over 20.5 | 0/50% | 2/1020% | 29/5157% |
| Over 21.5 | 0/50% | 0/100% | 25/5149% |
| Over 22.5 | 0/50% | 0/100% | 20/5139% |
| Over 23.5 – 24.5 | 0/50% | 0/100% | 19/5137% |
| Over 25.5 | 0/50% | 0/100% | 18/5135% |
| Over 26.5 | 0/50% | 0/100% | 17/5133% |
| Over 27.5 | 0/50% | 0/100% | 15/5129% |
| Over 28.5 – 30.5 | 0/50% | 0/100% | 12/5124% |
| Over 31.5 | 0/50% | 0/100% | 11/5122% |
| Over 32.5 | 0/50% | 0/100% | 8/5116% |
How often Max Shulga finished above each line. These are our own thresholds, not a sportsbook's — no odds are involved.